SJP-004

About Sen-Jam Pharmaceutical

Sen-Jam Pharmaceutical is an early-stage biotech pioneering a novel approach to immuno-regulation with its PAIR platform, which combines two repurposed molecules to modulate inflammation upstream. The company has a broad pipeline spanning from preclinical to Phase 2, targeting multi-trillion-dollar health burdens including obesity/MASH, opioid use disorder, respiratory infections, and critical care inflammation. By aiming to shift treatment paradigms from reactive symptom management to proactive immune modulation, Sen-Jam seeks to extend healthspan and reduce the global economic burden of chronic disease.

Therapeutic Areas